Abstract
Routine [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) may help predict clinical outcomes after response to immunotherapy. With an EMA-recommended treatment length until disease progression or unacceptable toxicity, the optimal duration of immunotherapy is still to be defined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
